{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T11:18:47Z","timestamp":1794568727753,"version":"4.9.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2008,9,25]],"date-time":"2008-09-25T00:00:00Z","timestamp":1222300800000},"content-version":"vor","delay-in-days":268,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiovascular Magnetic Resonance"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1186\/1532-429x-10-42","type":"journal-article","created":{"date-parts":[[2008,10,7]],"date-time":"2008-10-07T14:19:26Z","timestamp":1223389166000},"page":"42","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":471,"title":["Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance"],"prefix":"10.1016","volume":"10","author":[{"given":"Bernadette","family":"Modell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maren","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Darlison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A","family":"Westwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ingram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dudley J","family":"Pennell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1186\/1532-429X-10-42_bib1","series-title":"Health Services Research","article-title":"EC Concerted action on developing patient registers as a tool for improving service delivery for haemoglobin disorders","author":"Modell","year":"1993"},{"key":"10.1186\/1532-429X-10-42_bib2","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1136\/bmj.3.5829.737","article-title":"The incidence of beta thalassaemia trait among Cypriots in London","volume":"3","author":"Modell","year":"1972","journal-title":"Br Med J"},{"key":"10.1186\/1532-429X-10-42_bib3","article-title":"The Clinical Approach to Thalassaemia","author":"Modell","year":"1984","journal-title":"Grune and Stratton"},{"key":"10.1186\/1532-429X-10-42_bib4","first-page":"1006","article-title":"A national register for surveillance of inherited disorders: beta thalassaemia in the United Kingdom","volume":"79","author":"Modell","year":"2001","journal-title":"Bull World Health Organ"},{"key":"10.1186\/1532-429X-10-42_bib5","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/j.1749-6632.1965.tb54077.x","article-title":"The biochemistry of desferrioxamine and its relation to iron metabolism","volume":"119","author":"Keberle","year":"1964","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1186\/1532-429X-10-42_bib6","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1749-6632.1974.tb20586.x","article-title":"Long-term desferrioxamine therapy in thalassaemia","volume":"232","author":"Modell","year":"1974","journal-title":"Ann N Y Acad Sci"},{"key":"10.1186\/1532-429X-10-42_bib7","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/S0140-6736(00)02357-6","article-title":"Survival in beta thalassaemia major in the UK: data from the UK thalassaemia register","volume":"355","author":"Modell","year":"2000","journal-title":"Lancet"},{"key":"10.1186\/1532-429X-10-42_bib8","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/S0140-6736(76)92035-3","article-title":"Subcutaneous infusion and intramuscular injection of desferrioxamine in patients with transfusional iron overload","volume":"ii","author":"Hussain","year":"1976","journal-title":"Lancet"},{"key":"10.1186\/1532-429X-10-42_bib9","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0140-6736(82)90319-1","article-title":"Marrow transplantation for thalassaemia","volume":"ii","author":"Thomas","year":"1982","journal-title":"Lancet"},{"key":"10.1186\/1532-429X-10-42_bib10","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1136\/bmj.295.6612.1509","article-title":"Effective chelation of iron in beta thalassaemia with the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one","volume":"295","author":"Kontoghiorghes","year":"1987","journal-title":"Br Med J"},{"key":"10.1186\/1532-429X-10-42_bib11","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.beha.2004.08.026","article-title":"Deferiprone therapy for transfusional iron overload","volume":"18","author":"Hoffbrand","year":"2005","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1186\/1532-429X-10-42_bib12","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1053\/euhj.2001.2822","article-title":"Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload","volume":"23","author":"Anderson","year":"2001","journal-title":"Eur Heart J"},{"key":"10.1186\/1532-429X-10-42_bib13","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000089475","article-title":"Development of thalassaemic iron overload cardiomyopathy despite low liver iron levels and meticulous compliance to desferrioxamine","volume":"115","author":"Anderson","year":"2006","journal-title":"Acta Haematol"},{"key":"10.1186\/1532-429X-10-42_bib14","first-page":"685","article-title":"Transfusion iron overload cardiac dysfunction: lack of correlation with needle liver biopsy iron concentration","volume":"90","author":"Berdoukas","year":"2005","journal-title":"Haematologica"},{"key":"10.1186\/1532-429X-10-42_bib15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/jmri.10332","article-title":"A single breath-hold multiecho T2* cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload","volume":"18","author":"Westwood","year":"2003","journal-title":"J Magn Reson Imaging"},{"key":"10.1186\/1532-429X-10-42_bib16","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1080\/10976640600572889","article-title":"Normalized left ventricular systolic and diastolic function by steady state free precession cardiovascular magnetic resonance","volume":"8","author":"Maceira","year":"2006","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1186\/1532-429X-10-42_bib17","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S0140-6736(02)09740-4","article-title":"Comparison of effects of oral deferiprone and subcutaneous deferoxamine on myocardial iron concentrations and ventricular function in beta-thalassemia","volume":"360","author":"Anderson","year":"2002","journal-title":"Lancet"},{"key":"10.1186\/1532-429X-10-42_bib18","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1182\/blood-2005-07-2948","article-title":"Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis","volume":"107","author":"Pennell","year":"2006","journal-title":"Blood"},{"key":"10.1186\/1532-429X-10-42_bib19","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1080\/10976640600698155","article-title":"Myocardial iron loading in patients with thalassemia major on deferoxamine chelation","volume":"8","author":"Tanner","year":"2006","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1186\/1532-429X-10-42_bib20","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1182\/blood-2003-08-2841","article-title":"Value of sequential monitoring of left ventricular ejection fraction in the management of thalassemia major","volume":"104","author":"Davis","year":"2004","journal-title":"Blood"},{"key":"10.1186\/1532-429X-10-42_bib21","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1365-2141.2004.05202.x","article-title":"Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: A prospective study using T2* cardiovascular magnetic resonance","volume":"127","author":"Anderson","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1186\/1532-429X-10-42_bib22","unstructured":"Standards for the clinical care of children and adults with thalassaemia in the UK. The UK Thalassaemia Society. 2005, ISBN 1 900254 18 2."},{"key":"10.1186\/1532-429X-10-42_bib23","first-page":"489","article-title":"Comparative effects of deferiprone and deferoxamine on survival and cardiac disease in patients with thalassemia major: a retrospective analysis","volume":"88","author":"Piga","year":"2003","journal-title":"Haematologica"},{"key":"10.1186\/1532-429X-10-42_bib24","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1182\/blood-2005-07-2933","article-title":"Cardiac morbidity and mortality in deferoxamine- or deferiprone-treated patients with thalassemia major","volume":"107","author":"Borgna-Pignatti","year":"2006","journal-title":"Blood"},{"key":"10.1186\/1532-429X-10-42_bib25","first-page":"1187","article-title":"Survival of medically treated thalassemia patients in Cyprus. Trends and risk factors over the period 1980\u20132004","volume":"91","author":"Telfer","year":"2006","journal-title":"Haematologica"},{"key":"10.1186\/1532-429X-10-42_bib26","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1046\/j.1365-2141.1998.01002.x","article-title":"Combined therapy with deferiprone and desferrioxamine","volume":"103","author":"Wonke","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1186\/1532-429X-10-42_bib27","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1161\/CIRCULATIONAHA.106.648790","article-title":"A randomized, placebo controlled, double blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance","volume":"115","author":"Tanner","year":"2007","journal-title":"Circulation"},{"issue":"suppl","key":"10.1186\/1532-429X-10-42_bib28","doi-asserted-by":"crossref","first-page":"3838a","DOI":"10.1182\/blood.V106.11.3838.3838","article-title":"Myocardial T2* in patients with cardiac failure secondary to iron overload (abstr)","volume":"106","author":"Tanner","year":"2005","journal-title":"Blood"},{"key":"10.1186\/1532-429X-10-42_bib29","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s10554-005-0651-2","article-title":"Intercentre reproducibility of magnetic resonance T2* measurements of myocardial iron in thalassaemia","volume":"21","author":"Westwood","year":"2005","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1186\/1532-429X-10-42_bib30","first-page":"1388","article-title":"Multi-center validation of the transferability of the magnetic resonance T2* technique for the quantification of tissue iron","volume":"91","author":"Tanner","year":"2006","journal-title":"Haematologica"},{"key":"10.1186\/1532-429X-10-42_bib31","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1365-2141.2004.05202.x","article-title":"Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: A prospective study using T2* cardiovascular magnetic resonance","volume":"127","author":"Anderson","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1186\/1532-429X-10-42_bib32","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1532-429X-10-12","article-title":"Combined chelation therapy in thalassemia major for the treatment of severe myocardial siderosis with left ventricular dysfunction","volume":"10","author":"Tanner","year":"2008","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1186\/1532-429X-10-42_bib33","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0140-6736(89)90264-X","article-title":"Survival and causes of death in thalassaemia major","volume":"ii","author":"Zurlo","year":"1989","journal-title":"Lancet"},{"key":"10.1186\/1532-429X-10-42_bib34","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1128\/AAC.46.6.1741-1745.2002","article-title":"Comparison of the effects of deferiprone versus deferoxamine on growth and virulence of Yersinia enterocolitica","volume":"46","author":"Lesic","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1186\/1532-429X-10-42_bib35","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1086\/367656","article-title":"Klebsiella infection in patients with thalassemia","volume":"36","author":"Chung","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1186\/1532-429X-10-42_bib36","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1086\/378062","article-title":"Severe bacterial infection in transfusion-dependent patients with thalassemia major","volume":"37","author":"Wang","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1186\/1532-429X-10-42_bib37","first-page":"137","article-title":"Microbial iron-chelators and their action on Klebsiella infections in the skin of guinea-pigs","volume":"59","author":"Khimji","year":"1978","journal-title":"Br J Exp Pathol"},{"key":"10.1186\/1532-429X-10-42_bib38","first-page":"1388","article-title":"Multi-center validation of the transferability of the magnetic resonance T2* technique for the quantification of tissue iron","volume":"91","author":"Tanner","year":"2006","journal-title":"Haematologica"},{"key":"10.1186\/1532-429X-10-42_bib39","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/jmri.20681","article-title":"Development of a novel optimized breathhold technique for myocardial T2 measurement in thalassemia","volume":"24","author":"He","year":"2006","journal-title":"J Magn Reson Imaging"},{"key":"10.1186\/1532-429X-10-42_bib40","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/jmri.20929","article-title":"Black-blood T2* technique for myocardial iron measurement in thalassemia","volume":"25","author":"He","year":"2007","journal-title":"J Magn Reson Imaging"},{"key":"10.1186\/1532-429X-10-42_bib41","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1532-429X-10-11","article-title":"Multi-center transferability of a breath-hold T2 technique for myocardial iron assessment","volume":"10","author":"He","year":"2008","journal-title":"J Cardiovasc Magn Reson"}],"container-title":["Journal of Cardiovascular Magnetic Resonance"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1532-429X-10-42.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1532-429X-10-42\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1097664723012590?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1097664723012590?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1532-429X-10-42.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T01:05:02Z","timestamp":1761095102000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1097664723012590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S1097664723012590"],"URL":"https:\/\/doi.org\/10.1186\/1532-429x-10-42","relation":{},"ISSN":["1097-6647"],"issn-type":[{"value":"1097-6647","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiovascular Magnetic Resonance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1186\/1532-429X-10-42","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 THE AUTHORS. Published by Elsevier Inc on behalf of the Society for Cardiovascular Magnetic Resonance","name":"copyright","label":"Copyright"}],"article-number":"42"}}